Does blogging=journaling?

I just read this article about the benefits of journaling - taking pen to paper. The claims are it benefits your immune system, blood pressure and lung and liver function as well as allowing the right side of your brain to be creative. It also gives tip for getting started. But I've clearly already started. As long as blogging equals journaling. While I am not putting pen to paper, I am putting hands to keyboard and my right brain is working (I hope).The tips given are:write consistentlyconsider starting each day writingnever self editwrite about the good, the bad and the ugly.I would add to that -  if you have a brain like a sieve (like me), you can go back and read what you wrote so you can remember what you actually did that day. And ignore whatever your high school English teachers told you. Mine told me I couldn't form a cohesive paragraph and would never be a writer. But she was old and cranky too.
Source: Caroline's Breast Cancer Blog - Category: Cancer Tags: blogging brainless writing Source Type: blogs

Related Links:

Contributors : Girieca Lorusso ; Curzio RueggSeries Type : Expression profiling by arrayOrganism : Mus musculusWe recently established an orthotopic breast cancer model of brain metastasis based on the injection of murine breast cancer cell lines into the mammary fat pad. This model is based on the use of 4T1 murine breast carcinoma cells. 4T1-derived tumors recapitulate the main steps of human breast cancer progression, including epithelial-to-mesenchymal transition and metastases to lung and lymph nodes.Bioluminescence imaging revealed the appearance of secondary lesions to the lung and lymph nodes and sporadically to th...
Source: GEO: Gene Expression Omnibus - Category: Genetics & Stem Cells Tags: Expression profiling by array Mus musculus Source Type: research
Conclusion: S-ketamine is more effective for reducing POD for breast cancer patients. PMID: 31948296 [PubMed - as supplied by publisher]
Source: Journal of Investigative Surgery - Category: Surgery Tags: J Invest Surg Source Type: research
ConclusionsDisease progression occurred intracranially more often than extracranially following resection of a solitary BCBM. In ER+ patients, postoperative hormonal therapy was associated with longer OS. Postoperative HER2-targeted therapy did not show survival benefit in HER2+ patients. These results should be validated in larger cohorts.
Source: Breast Cancer Research and Treatment - Category: Cancer & Oncology Source Type: research
AbstractBrain metastases are the most common malignant tumors of the brain. Leptomeningeal dissemination is a late-stage complication of intracranial metastasis and portends an extremely poor prognosis. An increased risk of leptomeningeal disease (LMD) from metastatic breast cancer compared to other cancer types after stereotactic radiosurgery (SRS) has been reported. Validation of this observation has significant public health ramifications. The aim of this study was to determine the consistency of this association in the available literature via formal meta-analysis and systematic review of the literature. Searches of se...
Source: Clinical and Experimental Metastasis - Category: Cancer & Oncology Source Type: research
The separation of the brain from blood by the blood-brain barrier and the bloodcerebrospinal fluid (CSF) barrier poses unique challenges for the discovery and development of drugs targeting the central nervous system (CNS). This review will describe the role of transporters in CNS penetration and examine the relationship between unbound brain (Cu-brain) and unbound plasma (Cu-plasma) or CSF (CCSF) concentration. Published data demonstrate that the relationship between Cu-brain and Cu-plasma or CCSF can be affected by transporter status and passive permeability of a drug and CCSF may not be a reliable surrogate for CNS pene...
Source: Drug Metabolism Letters - Category: Drugs & Pharmacology Source Type: research
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.9b01167
Source: Molecular Pharmaceutics - Category: Drugs & Pharmacology Authors: Source Type: research
AbstractThe expression of cellular reporters to label cancer cells, such as green fluorescent protein (GFP) and luciferase, can stimulate immune responses and effect tumor growth. Recently, a mouse model that expresses GFP and luciferase in the anterior pituitary gland was generated to tolerize mice to these proteins; the “Glowing Head” mouse. Mice were obtained from a commercial vendor, bred, and then used for tumor growth and metastasis studies. The transgene expression of luciferase was assessed within tumor-naïve mice as well as mice with mammary tumors or metastases. Tumor-free mice with white fur, co...
Source: Clinical and Experimental Metastasis - Category: Cancer & Oncology Source Type: research
Journal of Proteome ResearchDOI: 10.1021/acs.jproteome.9b00664
Source: Journal of Proteome Research - Category: Biochemistry Authors: Source Type: research
In this study, taking into account the antiapoptotic and antioxidant activities of estrogens in neuronal cells, which are mediated by estrogen receptors, the possible estrogenic activity of aluminum in SH-SY5Y neuroblastoma cells was studied. Our results showed that aluminum in the form of aluminum chlorohydrate (ACH) exhibited no effect on estrogen receptors transcriptional activation, and differential effect on estrogen receptor alpha (ERα) and estrogen receptor beta (ERβ) protein levels. ACH caused reduction in ERβ protein levels, and increase in its mitochondrial localization. ACH-induced reduction in E...
Source: Neurotoxicology - Category: Neurology Authors: Tags: Neurotoxicology Source Type: research
A 64-year-old woman with metastatic breast cancer on follow-up had suspicious recurrent brain metastases. She underwent 18F-FDG PET/CT, 18F-PSMA 1007 brain PET/CT, and brain MRI. 18F-PSMA 1007 showed intense tracer localization in the suspected recurrent brain metastasis in right parietal lobe and also picked up 2 more metastatic brain lesions, which had concurrent findings of metastasis in subsequent MRI. Our case highlights the feasibility of 18F-PSMA 1007 PET/CT imaging of brain metastases from nonprostate cancers. It may be used as surrogate imaging tracer for potential theranostic application using alpha or beta emitt...
Source: Clinical Nuclear Medicine - Category: Nuclear Medicine Tags: Interesting Images Source Type: research
More News: Blogging | Brain | Brain Cancers | Breast Cancer | Cancer | Cancer & Oncology | Liver | Neurology | Teachers | Urology & Nephrology